Michael Schonfeld, Steven A
GPX4, Glutathione Peroxidase 4
BMI at 2-year follow-up, change in BMI from baseline, odds of reducing BMI category, and the need for treatment augmentation were exploratory outcomes
For example, Wegovy has been approved for certain individuals with heart disease and MASH (Metabolic Dysfunction-Associated Steatohepatitis)
In this regard, CoQ 10 oxidoreductases offer not only drug targets but also diagnostic nodes that report the state of ferroptosis defense
The biosynthesis of CoQ 10 involves distinct steps: production of the aromatic group that forms the quinone head, production of the isoprene tail, attachment of the quinone head to the isoprene tail, followed with slight biochemical modifications that lead to the formation of the final CoQ 10 product 8,9